Consensus AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Real-time Estimate Cboe BZX Other stock markets 16:00:38 2024-06-21 EDT			5-day change	1st Jan Change
80 ^USD	+1.83%		-0.73%	+17.31%

05:24pm	European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	MT
06-20	AstraZeneca Says Truqap With Faslodex Combination Approved in EU for Breast Cancer	MT

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

61c60ee5706bec5f14ac4e55261.Wg9YsDnWT7U5VN5XzURNqABPNNKiWTqhvgNg9x9HNFg.DjoJ1FflDv1cBZxmuwwmzTcfYr3BP2_F8m8IricERBQYNj_Idb4Y5EEH7g~20daefe9a5b1303065454d3192c26278

Analyst Recommendations on AstraZeneca PLC

ASTRAZENECA : Goldman Sachs maintains a Buy rating	06-18	ZD
Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco...	06-17
ASTRAZENECA : Berenberg raises its price target	06-10	CF
AstraZeneca shares outperform, Berenberg raises target	06-10	CF
Berenberg Raises AstraZeneca PT, Maintains Buy Rating	06-10	MT
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating	06-10	MT
JPMorgan cuts Aviva but lifts M&G	06-10	AN
ASTRAZENECA : Berenberg gives a Buy rating	06-10	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	06-07	ZD
HSBC Raises AstraZeneca PT, Keeps Buy Rating	06-05	MT
ASTRAZENECA : Deutsche Bank remains Neutral	06-05	ZD
ASTRAZENECA : Goldman Sachs reiterates its Buy rating	06-05	ZD
Berenberg raises Taylor Wimpey to 'buy'	06-05	AN
ASTRAZENECA : UBS reiterates advice after ASCO meeting	06-04	CF
ASTRAZENECA : Gets a Sell rating from UBS	06-04	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	06-03	ZD
Goldman Sachs Starts AstraZeneca With Buy Rating, $97 Price Target	05-30	MT
Goldman Sachs Kicks Off AstraZeneca Coverage at Buy	05-30	MT
Jefferies and UBS cut Anglo American	05-30	AN
ASTRAZENECA : Is no more a Sell but a Buy opportunity for Goldman Sachs	05-30	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	05-28	ZD
Stifel Raises AstraZeneca PT, Maintains Buy Rating	05-22	MT
ASTRAZENECA : Oddo BHF raises its target slightly	05-22	CF
Barclays cuts NextEnergy but lifts JLEN	05-22	AN
ASTRAZENECA : Gets a Neutral rating from Deutsche Bank	05-22	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

157.2 USD

Average target price

174.4 USD

Spread / Average Target

+11.00%

High Price Target

225.8 USD

Spread / Highest target

+43.69%

Low Price Target

137.4 USD

Spread / Lowest Target

-12.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

GOLDMAN SACHS	Rajan Sharma
Berenberg Bank
BERENBERG	Luisa Hector
JPMORGAN	James Gordon
HSBC
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
UBS	Matthew Weston
Stifel Nicolaus
Jefferies & Co.
JEFFERIES	Peter Welford
Barclays
DZ BANK	Elmar Kraus
alphavalue	Abhishek Raval
BERNSTEIN RESEARCH	Justin Smith
Deutsche Bank Securities
Bernstein
RBC Capital Markets
B. Riley
BMO Capital
CREDIT SUISSE	Dominic Lunn
Argus
Morgan Stanley
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK	Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar